BioLargo Inc (BLGO) Stock Analysis
Verdict: AVOID
Extreme valuation premium (6.3x P/S) and accelerating cash burn outweigh PFAS technology potential — insolvency risk is the primary headwind.
Investment score: 38/100
Analysis as of
Is BioLargo Inc stock worth reviewing? The TradeMates thesis
The TradeMates model views BioLargo as a high-risk speculative play with deteriorating fundamentals. While its PFAS remediation technology is relevant, the company's financial position is precarious, characterized by massive losses and a valuation that dwarfs its peer group. The model anticipates further dilution to fund the ~$8M annual cash burn.
7-factor investment score
- Valuation: 15/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 40/100 (weight 15%)
- Insider Sentiment: 50/100 (weight 10%)
- Analyst Consensus: 70/100 (weight 10%)
- Risk-Adjusted Return: 25/100 (weight 15%)
BioLargo Inc opportunities and risks
What speaks for BLGO
- PFAS Regulatory Tailwinds
What speaks against BLGO
- Imminent Liquidity Crunch and Dilution
Peers and competitors
- ALTO
- ACNT
- ARQ
- NTIC
- SLSN
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| BLGO | n/a | 6.3x | n/a | 42.3% | -230.1% | -26.8% |
| ALTO | 6.4x | 0.4x | 5.7x | 5.6% | 5.5% | 14.7% |
| ACNT | n/a | 1.7x | 177.2x | 20.8% | -5.3% | -6.0% |
| ARQ | n/a | 0.7x | n/a | 27.5% | -43.9% | -3.2% |
| NTIC | n/a | 0.9x | 19.5x | 35.8% | -1.3% | -4.7% |
| SLSN | 69.9x | 1.3x | 32.3x | 26.5% | 1.6% | -4.6% |
| Peer median | n/a | 0.9x | 19.5x | 26.5% | -1.3% | -4.6% |
Frequently asked questions about BioLargo Inc (BLGO)
Is BLGO stock a good investment?
The TradeMates model rates BioLargo Inc as AVOID with an investment score of 38/100. The TradeMates model views BioLargo as a high-risk speculative play with deteriorating fundamentals. While its PFAS remediation technology is relevant, the company's financial position is precarious, characterized by massive losses and a valuation that dwarfs its peer group. The model anticipates further dilution to fund the ~$8M annual cash burn. This is algorithmic model output, not personal investment advice.
Is BLGO stock a buy?
The TradeMates model verdict for BLGO is AVOID with an investment score of 38/100. Treat this as a model signal to review, not a personal buy recommendation.